kabutan

Soiken Holdings Inc.(2385) Summary

2385
TSE Growth
Soiken Holdings Inc.
259
JPY
-5
(-1.89%)
Feb 20, 3:30 pm JST
1.66
USD
Feb 20, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
225.2
PBR
1.12
Yield
3.86%
Margin Trading Ratio
Stock Price
Feb 20, 2026
Opening Feb 20, 9:00 am
261 JPY 1.68 USD
Previous Close Feb 19
264 JPY 1.70 USD
High Feb 20, 9:00 am
262 JPY 1.68 USD
Low Feb 20, 11:13 am
257 JPY 1.65 USD
Volume
108,800
Trading Value
0.03B JPY 0.18M USD
VWAP
259.46 JPY 1.67 USD
Minimum Trading Value
25,900 JPY 166 USD
Market Cap
6.77B JPY 0.04B USD
Number of Trades
140
Liquidity & Number of Trades
As of Feb 20, 2026
Liquidity
Mid
1-Year Average
223
1-Year High Dec 1, 2025
9,730
Margin Trading
Date Short Interest Long Margin Positions Ratio
Feb 13, 2026 0 1,078,500
Feb 6, 2026 0 1,052,200
Jan 30, 2026 0 1,042,200
Jan 23, 2026 0 1,005,300
Jan 16, 2026 0 978,100
Company Profile
Soiken Holdings Inc. is a venture business originating from Osaka University. The company's main focus is on cosmetics, but it also engages in functional food evaluation testing and anti-fatigue food products.
Sector
Services
Soiken Holdings Inc. was established as a biotech venture from Osaka University and operates in five business areas: bio-evaluation systems, healthcare support, cosmetics, health supplements, and functional ingredient development. In the bio-evaluation systems business, the company conducts evaluation tests using biomarkers and supports clinical research for pharmaceuticals. The healthcare support business offers services such as health checkups, specific health guidance, and diabetes severity prevention programs. The cosmetics business develops and markets its own brand using placenta extract. In the health supplements business, "Imida Peptide" is sold as the main product. The functional ingredient development business focuses on developing and selling functional materials such as lactoferrin.